| 摘要 |
Disclosed herein are beta-tubulin inhibitors of formula I, prodrugs thereof and therapeutically acceptable salts thereof, wherein R is selected from the group consisting of: t-butyl, i-propyl and sec-butyl and their use as anti-cancer cell proliferation agents.
|
